Sara H. Browne, M.D. is a Professor of Clinical Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego (UCSD). Dr. Browne received her undergraduate education at the University of Cape Town, RSA and her medical degree from the Oxford University School of Medicine. She has a master of public health from the Harvard University School of Public Health, where she was a Fulbright Scholar. She completed her license in the United Kingdom at the John Radcliffe Hospital, Oxford, UK. She did her residency in Internal Medicine at Stanford University Medical Center, where subsequently completed a Clinical Pharmacology Fellowship at Stanford University and an Infectious Diseases Fellowship at UCSD.
Since joining the UCSD faculty in 2006, Dr. Browne’s main focus has been Global Health and more recently Mobile Health. She has partnered with 3 institutions in South Africa (Stellenbosch University in the Western Cape and Rhodes University, Walter Sisulu University in the Eastern Cape) to support the development of skilled medically trained research faculty locally to better address clinical research questions crucial to the combat and treatment of the HIV/TB epidemics in Southern Africa. She has successfully mentored South African medical faculty in the design and development of three NIH-funded international HIV research projects in the areas of ART adherence, metabolic side effects in ART and transmitted HIV resistance. Research from these partnerships continue to yield both vital clinical data and clinical tools to implement in the field.
Dr. Browne currently conducts translational research and clinical trials to analyze and support patient medication adherence and promote medication literacy in the treatment of HIV/AIDS, TB, and chronic diseases. She seeks to provide new paradigms of healthcare delivery especially in the arena of patient self-management with the use of novel mobile health (mHealth) technologies. Her collaborators include. In collaboration with Proteus Digital Health., who have developed an ingestible event marker that is able to capture oral ingestion medication, Dr. Browne is investigating the efficacy of mHealth sensor technology to monitor treatment of Mycobacterium tuberculosis. She is an Alliance Healthcare Foundation Innovation Award recipient for this work.
Dr. Browne is the Principal Investigator in NIH R01 funded research into the use of ingestion sensor technology in the treatment and prevention of HIV infection. She is also funded to preform clinical trials on cell phone based remote vital sign monitoring.